Washington, D.C. – AdvaMedDx today announced that Hologic Chief Operating Officer Eric Compton has been named chairman of the AdvaMedDx Board of Directors for a two-year term.
Press Release | April 6, 2017
Press Release | April 6, 2017
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from Chief Advocacy Officer JC Scott following introduction in the U.S. Senate of legislation (S. 787) designed to expand Medicare beneficiary access to telehealth and remote monitoring services:
Press Release | April 4, 2017
WASHINGTON, D.C. – Advanced Medical Technology Association (AdvaMed) President and CEO Scott Whitaker testified before the Senate HELP Committee today on reauthorization of the Medical Device User Fee Act (MDUFA), stressing the urgent need for Congress to move forward with the agreement as negotiated between FDA and industry.
April 25, 2017 | AdvaMed Offices and Virtual
Learn more about how EXCITE International, a not-for-profit organization, can help your medical technology company navigate the notoriously complex pathway from innovation to ... Read More
April 25, 2017 | Washington, DC
This workshop is considered "Day 0" to the 10th Annual FDA/AdvaMed Medical Devices and Diagnostics Statistical Issues Conference. Professionals often attend both the workshop and the conference. The... Read More
Medical technology aids in the prevention, diagnosis and treatment of various conditions to enhance quality of life and help you enjoy more of life's precious moments.
Often undiagnosed, an estimated two to six million people in the United States have a serious heart condition called atrial fibrillation, or AFib. As those living with the disease know, complications from the irregular heartbeat caused by the AFib can be potentially devastating: The average person with AFib is five times more likely to suffer a stroke than someone with a regular heartbeat. Fortunately, there is innovative medical technology available today poised to make a real difference in...
WLF: Medical-Device Makers’ Representatives in the O.R.: Patient-Care Benefits and Legal Ramifications
When a doctor implants a medical device, he or she often requests the presence of a representative of the device manufacturer (a “rep”) in the operating room. Some observers are critical of this practice, demanding thatreps be barred from the O.R. At the same time,some lawyersthink repsin the O.R.should be subject to liability in the court system. This Legal Backgrounder explains why reps often play an important, if limited, role in the O.R., and why that role should not expose reps to lawsuits
ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes. The round was led by Philips and UPMC, through its innovation and commercialization arm UPMC Enterprises, with other new and existing investors participating. The funding will support a planned US-based pivotal trial for...
Imagine for a moment that you are one of the approximately 44 million women in the U.S. affected by cardiovascular disease, or one of the 24 million with osteoarthritis. You'd want access to the most advanced and effective care. Oftentimes, your doctor would recommend a medical technology or device as an essential component of your treatment – placing a stent in a blocked artery or replacing your knee or hip with a new artificial one, for example.
Mar. 09, 2017 - AdvaMed CEO Scott Whitaker discusses the impact of the medical device tax on business.